Usefulness of the Support Video “Talking Picture Book” for Overcoming Hesitancy to Start Galcanezumab Therapy
ABSTRACT Background Galcanezumab, approved in April 2021, is the first humanized monoclonal antibody against the calcitonin gene‐related peptide (CGRP) ligand to become available in Japan, but some patients with migraine are hesitant to start an anti‐CGRP antibody for a variety of reasons, particula...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | Brain and Behavior |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/brb3.70447 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|